Ketorolac is a non-steroidal anti-inflammatory drug (NSAID) commonly used to treat moderate to severe pain. It is available in both oral and injectable forms, and is generally considered safe when used as prescribed. However, like all medications, ketorolac can have some serious side effects. As such, it is important for doctors to be aware of these potential risks so that they can properly counsel their patients. In this article, we will take a comprehensive look at the hidden dangers of ketorolac and explore the potential side effects associated with its use.
Ketorolac is a non-steroidal anti-inflammatory drug (NSAID) that is used to treat pain. It is available in both oral and injectable forms, and is generally considered safe when used as prescribed. It works by blocking the production of certain chemicals in the body that cause pain and inflammation. Ketorolac is typically used to treat moderate to severe pain, such as that associated with arthritis, dental procedures, and traumatic injuries. It is also sometimes used to treat fever and inflammation.
Ketorolac is generally considered safe when used as prescribed. However, like all medications, it does carry the potential for side effects. Some of the most common side effects associated with ketorolac include nausea, vomiting, stomach pain, diarrhea, constipation, dizziness, headache, and drowsiness. In some cases, more serious side effects may occur, such as an increased risk of bleeding, kidney damage, and liver damage. It is important for doctors to be aware of these potential risks so that they can properly counsel their patients.
Certain individuals may be at an increased risk of experiencing side effects from ketorolac. These include people with a history of gastrointestinal problems, kidney or liver disease, and those taking other medications that may interact with ketorolac. It is important for doctors to ask their patients about their medical history and any other medications they may be taking before prescribing ketorolac.
Ketorolac should be taken exactly as prescribed by the doctor. The dosage and length of treatment will depend on the individual and the condition being treated. In general, ketorolac should not be taken for more than five days. Longer courses of treatment may increase the risk of side effects, so doctors should be sure to monitor their patients closely.
Ketorolac should not be taken by pregnant women, as it may cause harm to the fetus. Additionally, it should not be taken by people with a history of gastrointestinal bleeding or ulcers, as it can increase the risk of bleeding. It should also be avoided by those taking other medications that may interact with ketorolac, such as aspirin, warfarin, or other NSAIDs. Patients should be sure to inform their doctor of any other medications they are taking before starting ketorolac.
Ketorolac is a non-steroidal anti-inflammatory drug (NSAID) commonly used to treat moderate to severe pain. While it is generally considered safe when used as prescribed, it can have some serious side effects. As such, it is important for doctors to be aware of these potential risks so that they can properly counsel their patients. Patients should also be sure to inform their doctor of any other medications they are taking before starting ketorolac.
1.
A BRAF V600E mutation-positive intrathoracic synovial sarcoma is reported by researchers.
2.
No Survival Gain With Preoperative CRT Plus Perioperative Chemo for Gastric Cancer
3.
Innovative oncology therapeutics are being created in collaboration between Moderna and Immatics.
4.
An inoperable locally advanced NSCLC trial dubbed "Practice Changing".
5.
CDC Alerts on Dramatic Rise in Human Parvovirus B19
1.
All You Need To Know About Partial Thromboplastin Time (PTT) Test
2.
Machine Learning in Genomic Analysis for Early Lung Cancer Detection: Key Advances and Insights
3.
Survivin as a Key Regulator in Gynecological Cancers: Therapeutic and Prognostic Implications
4.
Rasburicase-Linked Methemoglobinemia in HCC: Risks, Mechanisms, and Management
5.
Unleashing the Inner Predator: Reprogramming Macrophages to Conquer Cancer Immunotherapy
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
2.
Navigating the Complexities of Ph Negative ALL - Part IV
3.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC
4.
Newer Immunotherapies for Myeloma- A Comprehensive Overview
5.
Navigating the Complexities of Ph Negative ALL - Part XII
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation